Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628898 · ClinicalTrials.gov registry record
Oxygen Reserve Index (ORi) Validation of INVSENSOR00025
A clinical trial, sponsored by Masimo Corporation.
- Completed
- Registry status
- 47
- Enrollment target
NCT03628898 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 47 participants.
The verdict
NCT03628898 has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
ORi is a unitless index that could help clinicians with their assessments or normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. Changes in ORi values are analyzed by comparing it to corresponding changes in PaO2 measurements from blood samples.
Interventions
- DEVICE INVSENSOR00025
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-07-26 |
| Est. Completion | 2018-08-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628898
The ClinicalTrials.gov registry entry for NCT03628898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00025 is the first listed.
NCT03628898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628898 about?
NCT03628898 is a clinical study titled "Oxygen Reserve Index (ORi) Validation of INVSENSOR00025". ORi is a unitless index that could help clinicians with their assessments or normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and...
What is the current status of trial NCT03628898?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2018-07-26. Estimated completion is 2018-08-09.
What interventions are being tested in trial NCT03628898?
The interventions under investigation include: INVSENSOR00025 (DEVICE).
Who is sponsoring clinical trial NCT03628898?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.